Cho, Byoung C
2730  Ergebnisse:
Personensuche X
?
1

Exploration of Immune-Modulatory Effects of Amivantamab in ..:

Lim, Sun M. ; Kang, Seong-san ; Kim, Dong K....
Cancer Research Communications.  4 (2024)  7 - p. 1748-1764 , 2024
 
?
5

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalu..:

Spigel, David R ; Faivre-Finn, Corinne ; Gray, Jhanelle E...
Spigel , D R , Faivre-Finn , C , Gray , J E , Vicente , D , Planchard , D , Paz-Ares , L , Vansteenkiste , J F , Garassino , M C , Hui , R , Quantin , X , Rimner , A , Wu , Y-L , Özgüroğlu , M , Lee , K H , Kato , T , Wit , M D , Kurata , T , Reck , M , Cho , B C , Senan , S , Naidoo , J , Mann , H , Newton , M , Thiyagarajah , P & Antonia , S J 2022 , ' Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer ' , Journal of Clinical Oncology . https://doi.org/10.1200/JCO.21.01308.  , 2022
 
?
6

Four-Year Survival With Durvalumab After Chemoradiotherapy ..:

Faivre-Finn, Corinne ; Vicente, David ; Kurata, Takayasu...
Faivre-Finn , C , Vicente , D , Kurata , T , Planchard , D , Paz-Ares , L , Vansteenkiste , J F , Spigel , D R , Garassino , M C , Reck , M , Senan , S , Naidoo , J , Rimner , A , Wu , Y L , Gray , J E , Özgüroğlu , M , Lee , K H , Cho , B C , Kato , T , de Wit , M , Newton , M , Wang , L , Thiyagarajah , P & Antonia , S J 2021 , ' Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial ' , Journal of Thoracic Oncology , vol. 16 , no. 5 , pp. 860-867 . https://doi.org/10.1016/j.jtho.2020.12.015.  , 2021
 
?
9

Overall survival with durvalumab after chemoradiotherapy in..:

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey...
Antonia , S J , Villegas , A , Daniel , D , Vicente , D , Murakami , S , Hui , R , Kurata , T , Chiappori , A , Lee , K H , De Wit , M , Cho , B C , Bourhaba , M , Quantin , X , Tokito , T , Mekhail , T , Planchard , D , Kim , Y , Karapetis , C S , Hiret , S , Ostoros , G , Kubota , K , Gray , J E , Paz-ares , L , De Castro Carpeño , J , Faivre-finn , C , Reck , M , Vansteenkiste , J , Spigel , D R , Wadsworth , C , Melillo , G , Taboada , M , Dennis , P A & Özgüroğlu , M 2018 , ' Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC : Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC ' , New England Journal Of Medicine , vol. 379 , no. 24 , pp. 2342-2350 . https://doi.org/10.1056/NEJMoa1809697.  , 2018
 
?
13

Safety and Efficacy of Dacomitinib in Korean Patients with ..:

Park, Keunchil ; Cho, Byoung C ; Kim, Dong-Wan...
Journal of Thoracic Oncology, Vol.9 No.10, pp.1523-1531.  , 2014
 
1-15